Cargando…
The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy
BTG (B-cell translocation gene) can inhibit cell proliferation, metastasis and angiogenesis, cell cycle progression, and induce differentiation in various cells. Here, we found that BTG3 overexpression inhibited proliferation, induced S/G2 arrest, differentiation, autophagy, apoptosis, suppressed mi...
Autores principales: | Gou, Wen-feng, Yang, Xue-feng, Shen, Dao-fu, Zhao, Shuang, Liu, Yun-peng, Sun, Hong-zhi, Takano, Yasuo, Su, Rong-jian, Luo, Jun-sheng, Zheng, Hua-chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637325/ https://www.ncbi.nlm.nih.gov/pubmed/25904053 |
Ejemplares similares
-
BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers
por: Zhao, Shuang, et al.
Publicado: (2016) -
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2015) -
Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
por: Deng, Boya, et al.
Publicado: (2013) -
BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013) -
ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression
por: Gou, Wen-feng, et al.
Publicado: (2015)